BloodFlow
BloodFlow uses AI to interpret blood test results within existing clinical systems.
The record
- Vertical
- Clinical AI & Documentation
- Sub-segment
- Blood test interpretation
- Product type
- Platform software
- Stage
- Seed
- Headquarters
- Portugal
- Region
- Europe
- Founded
- 2024
What they do
Founded in October 2024 and incubated at Unicorn Factory Lisboa, BloodFlow is led by founder and CEO Tiago Costa. ECO reports that the company integrates blood test interpretation into existing clinical systems through an API. Its official site describes it as “the invisible layer of clinical intelligence embedded in every EMR”. In July 2025, ECO reported a €1.2 million seed round led by 3xP Global through its Health Innovation Fund. Startup Portugal listed a BloodFlow pitch on the Portugal Stand at Web Summit Lisbon on 10 November 2026.
Investors
- 3xP Global